Zhou, Dao
Dai, Hanyi
Sheng, Wenjing
Zheng, Rongrong
Fan, Jiaqi
Yidilisi, Abuduwufuer
Aihemaiti, Ailifeire
Liu, Qiong
Chen, Jun
He, Yuxin
Guo, Yuchao
Zhu, Qifeng
Yang, Shuangshuang
Wei, Yanxia
Wang, Jian’an
Liu, Xianbao
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82200552, No. 81870292, No. 81570233, NO.81770252)
Natural Science Foundation of Zhejiang Province of China (LQ21H020005)
The National Key R&D Program of China (2019YFA0110400)
Zhejiang Research Center of Cardiovascular Diagnosis and Treatment Technology (JBZX-202001)
Zhejiang Province Science and Technology Department Key R&D Program (No.2024C03024, 2021C03097, 2018C03084, No.2022C03063)
National Science Fund for Distinguished Young Scholars of China (No.82425007)
Zhejiang Province Science and Technology Innovation Leading Talents Project (No.2023R5236)
Article History
Received: 13 September 2024
Accepted: 16 December 2024
First Online: 21 February 2025
Declarations
:
: The authors declare no competing interests.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Medical Ethics Committee of the Second Affiliated Hospital of Zhejiang University, Hangzhou, China.
: All patients provided written informed consent for the TAVR procedures and the use of anonymous data for research.